Folate receptor alpha (FRα) plays a significant role in breast cancer, particularly in aggressive subtypes such as triple-negative breast cancer (TNBC), in which it is overexpressed in approximately 71% of the cases [3]. Here, FOLR1 is linked to breast carcinoma.